211 related articles for article (PubMed ID: 6222505)
1. Platelet factor 4 (PF4) and heparin-released platelet factor 4 (HR-PF4) in patients with cardiovascular disorders.
Cella G; Colby SI; Taylor AD; McCracken L; Parisi AF; Sasahara AA
Thromb Res; 1983 Mar; 29(5):499-509. PubMed ID: 6222505
[TBL] [Abstract][Full Text] [Related]
2. Plasma beta-thromboglobulin and platelet factor 4 in patients with chronic renal failure and effect of hemodialysis.
Endo Y; Mamiya S; Satoh M; Takahashi K; Harada T
Tohoku J Exp Med; 1981 Dec; 135(4):349-58. PubMed ID: 6175048
[TBL] [Abstract][Full Text] [Related]
3. Platelet factor 4 (PF4) and heparin released platelet factor 4 (HR-PF4) in diabetes mellitus. Effect of the duration of the disease.
Cella G; Scattolo N; Vio C; Stevanato F; Lavagnini T; Padovan D; Girolami A
Folia Haematol Int Mag Klin Morphol Blutforsch; 1986; 113(5):646-54. PubMed ID: 2435630
[TBL] [Abstract][Full Text] [Related]
4. Heparin-releasable platelet factor 4 in patients with coronary artery disease.
Sadayasu T; Nakashima Y; Yashiro A; Kawashima T; Kuroiwa A
Clin Cardiol; 1991 Sep; 14(9):725-9. PubMed ID: 1835913
[TBL] [Abstract][Full Text] [Related]
5. A radioimmunoassay for thrombospondin, used in a comparative study of thrombospondin, beta-thromboglobulin and platelet factor 4 in healthy volunteers.
Dawes J; Clemetson KJ; Gogstad GO; McGregor J; Clezardin P; Prowse CV; Pepper DS
Thromb Res; 1983 Mar; 29(6):569-81. PubMed ID: 6190242
[TBL] [Abstract][Full Text] [Related]
6. Platelet factor 4 release induced by intravenous administration of heparin.
Cella G; Scattolo N; Cappellato MG; Girolami A; Strauss WE; Sasahara AA
Folia Haematol Int Mag Klin Morphol Blutforsch; 1985; 112(1):165-74. PubMed ID: 2581862
[TBL] [Abstract][Full Text] [Related]
7. Are platelet factor 4 and beta-thromboglobulin markers of cardiovascular disorders?
Cella G; Scattolo N; Girolami A; Sasahara AA
Ric Clin Lab; 1984; 14(1):9-18. PubMed ID: 6203164
[TBL] [Abstract][Full Text] [Related]
8. Selective PF4 release in vitro induced by heparin and related glycosaminoglycans (GAGs)--correlation with beta-TG release and platelet aggregation.
Cofrancesco E; Colombi M; Cristoforetti G; Pogliani EM
Thromb Haemost; 1984 Feb; 51(1):105-7. PubMed ID: 6202020
[TBL] [Abstract][Full Text] [Related]
9. [Clinical significance of the radioimmunological determination of beta-thromboglobulin and platelet factor 4].
Schernthaner G; Silberbauer K; Mühlhauser I; Willvonseder R
Acta Med Austriaca Suppl; 1979; 6():375-9. PubMed ID: 95543
[TBL] [Abstract][Full Text] [Related]
10. Relevance of platelet factor four (PF4) plasma levels in multiple sclerosis.
Cananzi AR; Ferro-Milone F; Grigoletto F; Toldo M; Meneghini F; Bortolon F; D'Andrea G
Acta Neurol Scand; 1987 Aug; 76(2):79-85. PubMed ID: 2960124
[TBL] [Abstract][Full Text] [Related]
11. The in vivo release of human platelet factor 4 by heparin.
Dawes J; Pumphrey CW; McLaren KM; Prowse CV; Pepper DS
Thromb Res; 1982 Jul; 27(1):65-76. PubMed ID: 6214868
[TBL] [Abstract][Full Text] [Related]
12. Platelet activation in patients with chronic pulmonary heart disease. Effect of dipyridamole treatment.
Zhang X; Ling P
Chin Med J (Engl); 1995 Feb; 108(2):95-7. PubMed ID: 7774397
[TBL] [Abstract][Full Text] [Related]
13. The release of beta-thromboglobulin and platelet factor 4 during extracorporeal circulation for open heart surgery.
Cella G; Vittadello O; Gallucci V; Girolami A
Eur J Clin Invest; 1981 Jun; 11(3):165-9. PubMed ID: 6168469
[TBL] [Abstract][Full Text] [Related]
14. [Clinical applications of beta-thromboglobulin and platelet factor 4 radioimmune assays (author's transl)].
Lokiec F; Najean Y
Nouv Presse Med; 1980 Oct; 9(38):2833-4, 2837-8. PubMed ID: 6160454
[TBL] [Abstract][Full Text] [Related]
15. Serial studies of platelet factor 4 and beta thromboglobulin during exercise in patients with coronary artery disease.
Strauss WE; Cella G; Parisi AF; Sasahara AA
Am Heart J; 1985 Aug; 110(2):293-9. PubMed ID: 2411121
[TBL] [Abstract][Full Text] [Related]
16. Plasma concentrations of plbatelet-specific proteins in coronary artery disease.
Mühlhauser I; Schernthaner G; Silberbauer K; Sinzinger H; Kaindl F
Cardiology; 1981; 68(3):129-38. PubMed ID: 6172197
[TBL] [Abstract][Full Text] [Related]
17. Fibrin formation and platelet aggregation in patients with acute myocardial infarction: effects of intravenous and subcutaneous low-dose heparin.
Gallino A; Haeberli A; Hess T; Mombelli G; Straub PW
Am Heart J; 1986 Aug; 112(2):285-90. PubMed ID: 2426934
[TBL] [Abstract][Full Text] [Related]
18. Secreted platelet proteins with antiheparin and mitogenic activities in chronic renal failure.
Guzzo J; Niewiarowski S; Musial J; Bastl C; Grossman RA; Rao AK; Berman I; Paul D
J Lab Clin Med; 1980 Jul; 96(1):102-13. PubMed ID: 6446588
[TBL] [Abstract][Full Text] [Related]
19. Increased releasability of platelet products and reduced heparin-induced platelet factor 4 release from endothelial cells in bronchial asthma.
Yasuba H; Chihara J; Kino T; Satake N; Oshima S
J Lipid Mediat; 1991; 4(1):5-21. PubMed ID: 1832572
[TBL] [Abstract][Full Text] [Related]
20. Influence of antiplatelet drugs on beta tg and PF4 levels in patients with transient ischemic attacks.
Fabris F; Randi ML; Casonato A; Dal Bo Zanon R; Manzoni S; Tonin P; De Zanche L; Girolami A
Adv Prostaglandin Thromboxane Leukot Res; 1985; 13():263-5. PubMed ID: 2408445
[No Abstract] [Full Text] [Related]
[Next] [New Search]
